Skip to main content

Our new paper “Lymph-Node Inspired Hydrogels Enhance CAR Expression and Proliferation of CAR T Cells” featured in the media

14 April 2025

La Vanguardia, The Munich Eye, iSanidad, Medical Xpress, Europa Press, MSN, and Infosalus among other media channels highlight our new research on the potential of bioengineered scaffolds in advancing the field of cell-based therapies.

TOC figure 4

Together with researchers from the Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)-Hospital Clínic de Barcelona, we have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, and proliferation of CAR T cells. This breakthrough could optimize the production of CAR T cells, a promising immunotherapy for cancer, by providing a more efficient and cost-effective platform for cell manufacturing.

More info can be found in the peer-reviwed paper:

Lymph-Node Inspired Hydrogels Enhance CAR Expression and Proliferation of CAR T Cells
Miquel Castellote-Borrell, Marc Domingo, Francesca Merlina, Huixia Lu, Salut Colell, Mireia Bachiller, Manel Juan, Sonia Guedan, Jordi Faraudo*, Judith Guasch*
ACS Appl. Mater. Interfaces 2025, 17, 11, 16548–16560
doi.org/10.1021/acsami.4c1994

And in the different media channels that featured the research:

 

Funding

This study has received funding from the “La Caixa” Foundation, through the CaixaImpulse Program (grant no. CI23-20216) and the Spanish Government through grants CNS2023-144236 (MICIU/AEI/10.13039/501100011033 and the European Union NextGenerationEU/PRTR), 2024ICT149, PID2020-115296RA-I00, PID2021-124297NB-C33, the Severo Ochoa Program for Centers of Excellence awarded to ICMAB (CEX2023-001263 S), FPI fellowships PRE2021-098161 and PRE2020-093689, Ramón y Cajal program (RYC-2018-024442-I. It has also been funded by the Government of Catalonia (AGAUR) through grant 2021SGR01519, and the Max Planck Society via the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy”, in collaboration with the Max Planck Institute for Medical Research (Heidelberg, Germany).